Hormonal Contraceptives, Female Sexual Dysfunction, and Managing Strategies: A Review
Autor: | Rubén de Alarcón, Angel L. Montejo, Nerea M. Casado-Espada, Berta Bote-Bonaechea, Javier I. de la Iglesia-Larrad |
---|---|
Rok vydání: | 2019 |
Předmět: |
libido
Sexual jealousy media_common.quotation_subject Female sexual dysfunction lcsh:Medicine Physiology Fertility Review Orgasm 03 medical and health sciences vaginal ring 0302 clinical medicine desire hormonal contraceptive medicine sex life orgasm 030212 general & internal medicine Etonogestrel media_common Libido 030219 obstetrics & reproductive medicine business.industry lcsh:R General Medicine medicine.disease depot medroxyprogesterone acetate Sexual dysfunction female sexual dysfunction Sex life medicine.symptom business medicine.drug |
Zdroj: | Journal of Clinical Medicine Journal of Clinical Medicine, Vol 8, Iss 6, p 908 (2019) |
ISSN: | 2077-0383 |
Popis: | In recent decades, hormonal contraceptives (HC) has made a difference in the control of female fertility, taking an unequivocal role in improving contraceptive efficacy. Some side effects of hormonal treatments have been carefully studied. However, the influence of these drugs on female sexual functioning is not so clear, although variations in the plasma levels of sexual hormones could be associated with sexual dysfunction. Permanent hormonal modifications, during menopause or caused by some endocrine pathologies, could be directly related to sexual dysfunction in some cases but not in all of them. HC use seems to be responsible for a decrease of circulating androgen, estradiol, and progesterone levels, as well as for the inhibition of oxytocin functioning. Hormonal contraceptive use could alter women’s pair-bonding behavior, reduce neural response to the expectation of erotic stimuli, and increase sexual jealousy. There are contradictory results from different studies regarding the association between sexual dysfunction and hormonal contraceptives, so it could be firmly said that additional research is needed. When contraceptive-related female sexual dysfunction is suspected, the recommended therapy is the discontinuation of contraceptives with consideration of an alternative method, such as levonorgestrel-releasing intrauterine systems, copper intrauterine contraceptives, etonogestrel implants, the permanent sterilization of either partner (when future fertility is not desired), or a contraceptive ring. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |